BAY86-9596
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY86-9596, covering 2013-01-21 to 2013-01-21. Get the full timeline:
Most recent: Clinical Trial Update: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations [Phase 1]